Image credit: Wandong booth, ChinaMed 2017
On the 29th April, Beijing Wandong Medical Technology published its financial results for Q1 2020. This show that the company delivered explosive sales growth during the first quarter. Total company sales revenue reached RMB¥ 250m, compared with RMB¥ 162m during Q1 2019, an increase of approximately 55% year-on-year.
The sales growth during the first quarter was driven by increased product demand stimulated by the Coronavirus pandemic. This was mainly increased demand for mobile digital radiography (DR) systems. Higher sales revenue from mobile DR systems were partially offset by slower sales revenue originating from the companies other products lines which were non-pandemic related.
Beijing Wandong Medical Technology Co., Ltd. engages in the research and development, manufacturing, and sale of medical diagnostic equipment. The company offers MRI solutions; radiological imaging solutions, including CT system, CGO series, DR system, DRF system, digital mammography, general and mobile X-ray, and C-arm equipment; and veterinary imaging solutions. It operates in approximately 70 countries worldwide. The company was formerly known as China Resources Wandong Medical Equipment Co., Ltd. The company was founded in 1955 and is headquartered in Beijing, China.